Janus Henderson Group’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLRB
Janus Henderson Group's CLRB Position: Q3 2026 in Review
Janus Henderson Group opened a new position in Cellectar Biosciences (CLRB) in Q3 2026: 465,999 shares worth $860K. The stake represents ﹤0.01% of the portfolio and ranks #1841 among its holdings.
28 funds tracked by Wall St. Rank hold CLRB as of Q3 2026.
- Janus Henderson Group held 465,999 shares of Cellectar Biosciences worth $860K as of Q3 2026.
- Cellectar Biosciences was a new Janus Henderson Group position in Q3 2026.
- Cellectar Biosciences made up ﹤0.01% of Janus Henderson Group's portfolio in Q3 2026, its #1841 holding.
- 28 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.